Kanwar, Pushpjeet
Nelson, James E
Yates, Katherine
Kleiner, David E
Unalp-Arida, Aynur
Kowdley, Kris V
Clinical trials referenced in this document:
Documents that mention this clinical trial
Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
https://doi.org/10.1136/bmjgast-2016-000114
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
https://doi.org/10.1136/bmjgast-2019-000368
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
https://doi.org/10.1136/gutjnl-2019-319104
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
https://doi.org/10.1016/j.cct.2016.02.012
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
https://doi.org/10.1136/gutjnl-2022-327498
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
https://doi.org/10.1016/j.cct.2008.09.003